首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷分子呈像/呈影劑

造影注射器市場規模、佔有率和成長分析（按產品、類型、應用、最終用途和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1898706

造影注射器市場規模、佔有率和成長分析（按產品、類型、應用、最終用途和地區分類）－2026-2033年產業預測

Contrast Media Injectors Market Size, Share, and Growth Analysis, By Product (Injector Systems, Consumables), By Type (Single Head Injectors, Dual-Head Injectors), By Application, By End Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 188 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球造影注射器市場規模將達到 20.6 億美元，到 2025 年將達到 22.2 億美元，到 2033 年將達到 41.8 億美元，預測期（2026-2033 年）的複合年成長率為 8.2%。

全球造影注射器市場受到心血管疾病、癌症和神經系統疾病等慢性病日益普遍的顯著影響。精準影像對於有效診斷這些疾病至關重要，而人口老化和對診斷影像檢查日益重視進一步推動了市場需求的激增。這促使醫療機構投資於能夠提高影像品質並最佳化造影劑使用的先進注射器。此外，醫療產業正日益轉向微創技術，從而推動了對高精度輸送系統的需求。諸如從手動系統向自動化系統的轉變以及雙頭注射器的引入等技術進步，正在提高成像精度和工作流程效率，最終推動市場成長，並促進醫療機構採用現代造影注射器。

全球造影注射器市場促進因素

癌症、心血管疾病和糖尿病等慢性疾病發病率的上升推動了對早期診斷影像解決方案的需求。對這些健康狀況快速診斷和監測需求的日益成長，促使醫療機構增加造影輸液設備的使用。這一趨勢反過來又促進了先進成像技術的應用，並顯著推動了市場擴張。此外，人們越來越意識到早期檢測在改善患者預後方面的重要性，這進一步刺激了對高效能造影輸液設備的需求，從而改善了醫療影像產業的整體環境。

全球造影注射器市場的阻礙因素

醫療設備（例如造影注射器）的監管環境複雜，為產品核可和市場准入帶來了巨大挑戰。不同地區監管力度的差異會阻礙創新解決方案的及時推出，最終限制產業成長前景，並抑制先進技術的應用。因此，製造商可能難以應對合規的複雜問題，從而扼殺創新，限制新產品的交付以滿足不斷變化的市場需求，進而影響整個市場的發展和擴張。

全球造影注射器市場趨勢

在人工智慧 (AI) 技術的推動下，全球造影注射器市場正經歷重大變革。 AI 的整合透過針對個別患者參數最佳化造影給藥方案，提高了診斷影像的準確性、效率和安全性，最終降低了造影腎臟病等疾病的風險。 AI 賦能的注射器具備自動化功能，可簡化工作流程並最大限度地減少人為錯誤，從而減少放射科的資源浪費。此外，預測分析能夠實現個人化成像通訊協定，進一步提高診斷結果的準確性。隨著 AI 在醫學影像領域的應用日益廣泛，AI 在造影輸液設備中的應用有望推動患者照護的創新和市場成長。這反映了以技術主導的醫療解決方案這一更廣泛的趨勢。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Bayer AG（Germany）
Medtronic plc（Ireland）
Bracco Imaging SpA（Italy）
Guerbet（France）
Nemoto Kyorindo Co., Ltd.（Japan）
Ulrich GmbH & Co. KG（Germany）
APOLLO RT Co., Ltd.（Japan）
Shenzhen Anke High-tech Co., Ltd.（China）
SinoMD Technology Co., Ltd.（China）
Vivid Medical Imaging Products Co., Ltd.（China）
Mallinckrodt plc（Ireland）
GE Healthcare（USA）
Siemens Healthineers AG（Germany）
Philips（Netherlands）
Terumo Corporation（Japan）
Cook Medical（USA）
Acist Medical Systems, Inc.（USA）

結論與建議

簡介目錄

Product Code: SQMIG55A2056

Global Contrast Media Injectors Market size was valued at USD 2.06 Billion in 2024 and is poised to grow from USD 2.22 Billion in 2025 to USD 4.18 Billion by 2033, growing at a CAGR of 8.2% during the forecast period (2026-2033).

The global contrast media injectors market is significantly influenced by the rising prevalence of chronic diseases such as cardiovascular conditions, cancer, and neurological disorders, which necessitate accurate imaging for effective diagnosis. This surge in demand is further driven by an aging population combined with a growing emphasis on diagnostic imaging procedures, prompting healthcare facilities to invest in advanced injectors that enhance image quality and optimize contrast media usage. Additionally, the industry is experiencing a shift towards minimally invasive techniques, increasing the need for high-precision delivery systems. Technological advancements, including the move from manual to automated systems and the introduction of dual-head injectors, are enhancing imaging accuracy and workflow efficiency, ultimately driving market growth and promoting the adoption of modern contrast media injectors in healthcare settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Contrast Media Injectors market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Contrast Media Injectors Market Segments Analysis

Global Contrast Media Injectors Market is segmented by Product, Type, Application, End Use and region. Based on Product, the market is segmented into Injector Systems, Consumables and Accessories. Based on Type, the market is segmented into Single Head Injectors, Dual-Head Injectors and Syringeless Injectors. Based on Application, the market is segmented into Radiology, Interventional Cardiology and Interventional Radiology. Based on End Use, the market is segmented into Hospitals, Diagnostic Centers and Ambulatory Surgery Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Contrast Media Injectors Market

The rising incidence of chronic illnesses such as cancer, cardiovascular diseases, and diabetes is driving the demand for early diagnostic imaging solutions. This heightened need for prompt diagnosis and monitoring of these health conditions is prompting healthcare providers to increasingly utilize contrast media injectors. As a result, this trend is significantly contributing to the expansion of the market, as it promotes the adoption of advanced imaging technologies. Consequently, the growing awareness of the importance of early detection in improving patient outcomes is further stimulating the demand for effective contrast media injectors, thereby enhancing the overall landscape of the healthcare imaging sector.

Restraints in the Global Contrast Media Injectors Market

The intricate regulatory landscape governing medical devices, such as contrast media injectors, poses significant challenges that can cause delays in obtaining product approvals and entering the market. Variations in stringent regulations across different regions may obstruct the timely introduction of innovative solutions, ultimately restricting growth prospects and hindering the adoption of advanced technologies within the industry. As a result, manufacturers may find it difficult to navigate the complexities of compliance, which can stifle innovation and limit the availability of new products to meet evolving market demands, thereby impacting overall market development and expansion.

Market Trends of the Global Contrast Media Injectors Market

The Global Contrast Media Injectors market is witnessing a significant transformation driven by advancements in Artificial Intelligence (AI). AI integration enhances precision, efficiency, and safety in diagnostic imaging by optimizing contrast dosing tailored to individual patient parameters, ultimately reducing risks such as contrast-induced nephropathy. The automation capabilities of AI-powered injectors streamline workflows and minimize human errors, which leads to reduced waste in radiological practices. Moreover, predictive analytics facilitate personalized imaging protocols, enhancing diagnostic outcomes. As the adoption of AI in medical imaging escalates, its role in contrast media injectors is poised to revolutionize patient care and propel market growth, reflecting a broader trend towards tech-driven healthcare solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Contrast Media Injectors Market Size by Product & CAGR (2026-2033)

Market Overview
Injector Systems
- CT injector systems
- MRI injector systems
- Cardiovascular/angiography injector systems
Consumables
- Tubing
- Syringe
- Others

Global Contrast Media Injectors Market Size by Type & CAGR (2026-2033)

Market Overview
Single Head Injectors
Dual-Head Injectors
Syringeless Injectors

Global Contrast Media Injectors Market Size by Application & CAGR (2026-2033)

Market Overview
Radiology
Interventional Cardiology
Interventional Radiology

Global Contrast Media Injectors Market Size by End Use & CAGR (2026-2033)

Market Overview
Hospitals
Diagnostic Centers
Ambulatory Surgery Centers

Global Contrast Media Injectors Market Size & CAGR (2026-2033)

North America (Product, Type, Application, End Use)
- US
- Canada
Europe (Product, Type, Application, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Type, Application, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Type, Application, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Type, Application, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bracco Imaging S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guerbet (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nemoto Kyorindo Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ulrich GmbH & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
APOLLO RT Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shenzhen Anke High-tech Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SinoMD Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vivid Medical Imaging Products Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mallinckrodt plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Acist Medical Systems, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments